SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-040380
Filing Date
2017-08-03
Accepted
2017-08-03 17:18:38
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471203_10q.htm 10-Q 327908
2 EXHIBIT 10.1 v471203_ex10-1.htm EX-10.1 124580
3 EXHIBIT 31.1 v471203_ex31-1.htm EX-31.1 11153
4 EXHIBIT 31.2 v471203_ex31-2.htm EX-31.2 10831
5 EXHIBIT 32.1 v471203_ex32-1.htm EX-32.1 4400
6 EXHIBIT 32.2 v471203_ex32-2.htm EX-32.2 4360
  Complete submission text file 0001144204-17-040380.txt   4033066

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT iova-20170630.xml EX-101.INS 971753
8 XBRL TAXONOMY EXTENSION SCHEMA iova-20170630.xsd EX-101.SCH 34389
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20170630_cal.xml EX-101.CAL 27961
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20170630_def.xml EX-101.DEF 256633
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20170630_lab.xml EX-101.LAB 275221
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20170630_pre.xml EX-101.PRE 292564
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 171006077
SIC: 2836 Biological Products, (No Diagnostic Substances)